G1 Therapeutics Announces Inducement Grants Under Nasdaq
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a
Globe Newswire2-02-2023, 04:47
Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients 2-01-2024, 20:00